On the morning of March 21, 2026, the 23rd China International Exhibition on Clinical Laboratory and Blood Transfusion Instruments & Reagents & the 6th China International Exhibition on IVD Upstream Raw Materials & Supply Chain (CACLP), organized by Zhi'ao Ruihe (Shanghai) Exhibition Co., Ltd., grandly opened at the Xiamen International Convention and Exhibition Center!

As a flagship global exhibition for in vitro diagnostics, this year’s event is unprecedented in scale, bringing together more than 1,200 exhibitors from over 20 countries and regions. It facilitates collaboration and exchange among experts and scholars from the upstream, midstream, and downstream sectors—including raw material manufacturers, reagent and instrument producers, distributors, and third-party laboratory service providers—from more than 50 countries and regions worldwide, attracting over 100,000 professional visitors to join in the festivities.

Suzhou Coninno Biotechnology Co., Ltd. made a major debut, showcasing its full range of core allergen products and innovative solutions developed using its proprietary matrix detection technology, which is exclusive in China.

Coninno has been deeply involved in the field of allergen testing for many years. Guided by the philosophy that “innovation shapes the future, and quality determines value,” the company focuses on the research, development, production, and commercialization of core allergen raw materials, testing reagents, supporting instruments, and comprehensive diagnostic solutions.

The booth remained bustling with visitors throughout the event. The sales and technical teams provided professional explanations and attentive service, offering each guest a detailed overview of the products’ technical advantages, performance specifications, and clinical applications. They also listened carefully to customer needs, addressed technical questions on a one-on-one basis, and engaged in in-depth discussions regarding potential collaborations. As a result, the company received a significant number of expressions of interest and positive industry feedback on the very first day.

This participation in CACLP serves not only as a key platform for Coninno to showcase its technological capabilities and brand image to the entire industry, but also marks a new starting point for deepening our collaboration and joining forces with our strategic partner, Xinsaiya.

Moving forward, Coninno will remain true to its founding mission, continue to increase investment in R&D, focus on the in vitro diagnostics sector, and constantly break through technological barriers to develop more high-quality IVD products and solutions that meet clinical needs and drive industry development. At the same time, we will continue to deepen our comprehensive strategic partnership with Xinsaya, further integrating our respective strengths, expanding the scope of our collaboration, and enhancing technological synergy. By leveraging a synergistic industrial force where 1+1>2, we will jointly empower the high-quality development of China’s in vitro diagnostics industry and make a solid contribution to advancing precision medicine and safeguarding public health!

About CACLP

CACLP, the China International Exhibition on Laboratory Medicine and Blood Transfusion, is a flagship industry event of significant global influence in the field of in vitro diagnostics (IVD). Founded in 1991 as the National Association of Medical Laboratory Supplies Production, Supply, and Sales, it was officially renamed and commercialized in 2004 and is held annually. The exhibition integrates product displays, academic exchanges, brand promotion, supply chain development, investment and financing, and business negotiations. Exhibits cover the entire industry chain, including hematology, biochemistry, immunology, molecular diagnostics, transfusion, and life science instruments and reagents. It brings together global IVD companies, clinical experts, research institutions, and investors, serving as a central hub for technological innovation, market trends, and industrial collaboration.